Farnesyl-transferase inhibitors show synergistic anticancer effects in combination with novel KRAS-G12C inhibitors

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Mechanism-based cancer therapy: resistance to therapy, therapy for resistance2014 · 271 citations
2. 2KRYSTAL-1: Activity and Safety of Adagrasib (MRTX849) in Patients with Colorectal Cancer (CRC) and Other Solid Tumors Harboring a KRAS G12C Mutation2020 · 79 citations
3. 3Oncogenic and Wild-type Ras Play Divergent Roles in the Regulation of Mitogen-Activated Protein Kinase Signaling2012 · 215 citations
4. 4Adagrasib: First Approval2023 · 142 citations
5. 5The current state of the art and future trends in RAS-targeted cancer therapies2022 · 520 citations